Last reviewed · How we verify
NCT03542721
A Placebo-controlled, Randomized, Double-blind, Parallel, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of DA-5515 (Circulan® Soft Cap.) in Patients With Chronic Fatigue Symptoms Due to Impaired Blood Circulation
Phase 4 trial testing DA-5515 in Fatigue Symptom in 204 participants. Status unknown.
1 June 2019
Quick facts
| Lead sponsor | Dong-A Pharmaceutical |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 204 |
| Start date | 17 January 2018 |
| Primary completion | 1 June 2019 |
| Estimated completion | 1 December 2019 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- DA-5515 — full drug profile →
- Placebo of DA-5515 — full drug profile →
Conditions studied
- Fatigue Symptom — all drugs for Fatigue Symptom →
Sponsor
Dong-A Pharmaceutical — full company profile →
Who can join
Adults 19 to 79, any sex, with Fatigue Symptom. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
CIS(Checklist Individual Strength) less than or equal to 76
Time frame: 8weeks
Rate of subjects whose CIS score has improved less than or equal to 76 at 8weeks
Sponsor's own description
The aim of the present clinical study is to evaluate the efficacy and safety of the DA-5515 (Circulan Soft Cap.) in patients with chronic fatigue symptoms due to impaired blood circulation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03542721
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fatigue Symptom
Currently open trials in the same condition.
- NCT07278973 — Hemodiafiltration Versus Hemodialysis in Older People · NA · recruiting
- NCT07281300 — Mindfulness-Oriented Respiratory Distress Symptom Intervention for Lung Cancer · NA · recruiting
- NCT06994104 — Exploring the Effects of Smartphone and Game Addiction on Activity, Sleep, Stress, and Pain in Youth · recruiting
- NCT07135791 — Monitoring Fatigue In Daily Life In Adults With Cerebral Palsy or Acquired Brain Injury · recruiting
- NCT06650813 — Adapting the FACETS Program to Sickle Cell Disease · NA · recruiting
Other Dong-A Pharmaceutical trials
Trials by the same sponsor.
- NCT07458828 — Evaluate the Efficacy and Safety of Hydrolyzed Keratin Peptide Powder on Hair Health · NA · completed
- NCT03117153 — Effect of a Liquid Toothpaste on Periodontal Disease · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03542721 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dong-A Pharmaceutical
- Last refreshed: 1 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03542721.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing